Exposure to per- and polyfluoroalkyl substances elicits cell type-specific impacts on p53 and TGF-β signaling pathways

This study demonstrates that exposure to the PFAS compounds PFOA and GenX induces cell type-specific cytotoxicity and distinct perturbations in p53-mediated DNA damage response and TGF-β/SMAD inflammatory signaling pathways across human skin, liver, kidney, and colon cell lines, with GenX generally exhibiting lower toxicity than PFOA.

The Gist

The Big Picture: The "Forever Chemical" Swap

Imagine you have a very sticky, indestructible tape (let's call it PFOA). It's great for keeping things together, but it never breaks down. It sticks to your hands, your clothes, and even your insides if you eat it. Because it's so harmful and stays in the environment forever, scientists and companies decided to swap it out for a new, "safer" tape called GenX.

The idea was: "GenX is shorter and breaks down faster, so it must be safer, right?"

This study asked a very important question: Is the new tape actually safer, or does it just break in a different, hidden way?

To find out, the researchers didn't just look at the tape; they looked at what happens inside the "factory" (our cells) when they are exposed to both the old tape (PFOA) and the new tape (GenX). They tested four different types of factories: Skin, Liver, Kidney, and Colon.

---

The Experiment: Stressing Out the Factories

The researchers put these four cell factories under a microscope and exposed them to different amounts of PFOA and GenX. They wanted to see two things:

1. How much poison does it take to shut the factory down? (Cytotoxicity)
2. What alarms go off inside the factory before it shuts down? (Molecular Stress)

1. The "Shut Down" Test (Cytotoxicity)

Think of the cells like a group of people in a room. If you throw a heavy rock at them (PFOA), they get knocked out quickly. If you throw a lighter, fluffier pillow (GenX), they can handle it better.

• The Result: The "old tape" (PFOA) was much more toxic. It knocked out the cells at much lower doses. The "new tape" (GenX) was indeed less toxic in terms of immediate damage; the cells could survive higher doses of it.
• The Catch: Just because the factory didn't collapse immediately doesn't mean the workers are happy. The "safer" tape might be causing silent, internal chaos.

2. The Internal Alarms (The Molecular Pathways)

This is where the story gets interesting. Even though GenX didn't kill the cells as fast, it tripped different internal alarms than PFOA did. The researchers looked at three main security systems inside the cells:

• The DNA Damage Crew (p53, ATM, ATR): Imagine these are the security guards who check if the blueprints (DNA) are torn. If the blueprints are ripped, they stop the factory to fix them.
• The Ribosome Stress Sensors (RPL5, RPL11): These are like the machinery maintenance team. If the machines (ribosomes) that build proteins start jamming, these sensors sound the alarm.
• The Inflammation Team (TGF-β/SMAD): This is the fire department. When things go wrong, they send out signals to fix the damage, but sometimes they overreact and cause swelling (inflammation) or scarring (fibrosis).

The Twist: Different Factories, Different Reactions

The most surprising discovery was that different organs react differently to the same chemicals. It's not a "one size fits all" problem.

• The Liver (HepG2) and Skin (A375): These two factories were similar. When hit with the chemicals, they both sounded the DNA damage alarms and the inflammation sirens. They were basically saying, "We are under attack, stop everything and fix the blueprints!"
• The Kidney (SN12C) and Colon (SW620): These two were the rebels. They reacted in opposite ways depending on which chemical was used.
  • Example: In the Kidney, PFOA made the security guards go to sleep (turn off), but GenX woke them up. In the Colon, it was the exact opposite: PFOA woke the guards up, but GenX made them go to sleep.

The Analogy: Imagine two different car models.

• If you pour PFOA into a Toyota, the engine light comes on, and the brakes lock up.
• If you pour GenX into that same Toyota, the engine runs fine, but the radio starts playing static.
• But if you pour PFOA into a Ford, the radio plays static.
• If you pour GenX into the Ford, the brakes lock up.

The Lesson: You can't just test a chemical on one type of cell and assume it's safe for everyone. The "new" chemical might be safe for your liver but dangerous for your kidneys, or vice versa.

The "Silent" Danger: Ribosomal Stress

The study also looked at RPL5 and RPL11. Think of these as the "nucleolar stress" sensors. They are like the quality control inspectors on an assembly line. If the assembly line (ribosome) gets jammed, these inspectors stop the whole factory and call the police (p53).

The researchers found that GenX and PFOA jammed these assembly lines in different ways. Sometimes GenX jammed the line in the kidney, while PFOA jammed it in the colon. This suggests that even if a chemical doesn't kill the cell immediately, it might be messing with the cell's ability to build proteins correctly, which can lead to long-term diseases like cancer.

The Conclusion: "Safer" Doesn't Mean "Harmless"

The study concludes that GenX is indeed less toxic than PFOA in terms of killing cells quickly. However, it is not biologically inert (inactive).

• The Takeaway: Just because a chemical is a "replacement" doesn't mean it's a perfect substitute. It has a different "personality." It might hurt your liver less, but it could confuse your kidneys or colon in ways we didn't expect.
• The Warning: We need to stop assuming that if a chemical is "less toxic" in one test, it's safe for everything. We need to check how it affects every single organ system, because they all speak a different language.

In short: We swapped a heavy rock for a pillow. The pillow didn't knock us out as fast, but it might still be hitting us in the head in a way we didn't see coming. We need to be careful with the "safer" options, too.

Technical Summary

1. Problem Statement and Rationale

Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with significant toxicological concerns. While Perfluorooctanoic acid (PFOA) is a well-studied legacy PFAS linked to hepatotoxicity and metabolic disorders, it has been largely replaced by GenX (hexafluoropropylene oxide dimer acid), marketed as a safer alternative due to its shorter chain length. However, emerging evidence suggests GenX may also be toxic, yet its mechanistic effects compared to PFOA remain under-characterized.

Key Knowledge Gaps:

• Most studies focus on serum levels or liver toxicity, lacking a comparative analysis across multiple tissue types (skin, kidney, colon).
• It is unclear if legacy and replacement PFAS elicit distinct mechanistic responses or converge on common stress pathways.
• The involvement of ribosomal stress (mediated by RPL5/RPL11) and specific DNA damage response (DDR) regulators (ATM, ATR, p53) in PFAS toxicity is largely unexplored.

Hypothesis: PFOA and GenX elicit distinct, cell-type-specific responses in key stress pathways, including TGF-β-mediated inflammation/fibrosis and p53-mediated DNA damage responses.

2. Methodology

The study utilized an in vitro approach to compare the cytotoxic and molecular effects of PFOA and GenX across four human-derived cancer cell lines representing different organ systems:

• Cell Lines:

  • Skin: A375 (Melanoma)
  • Liver: HepG2 (Hepatocellular carcinoma)
  • Kidney: SN12C (Renal cell carcinoma)
  • Colon: SW620 (Colorectal cancer)

• Experimental Design:

  • Exposure: Cells were treated with varying concentrations of PFOA and GenX for 48 hours. Concentrations ranged from 0 to 4,000 µM.
  • Cytotoxicity: Assessed using the CCK-8 assay to determine cell viability and calculate half-maximal inhibitory concentrations (IC50).
  • Molecular Analysis:
    • Gene Expression: Quantitative PCR (qPCR) was used to measure mRNA levels of key markers: TGF-β1/2/3, SMAD1-4, ATM, ATR, p53, RPL5, and RPL11.
    • Protein Expression: Western Blotting (Immunoblotting) was performed to quantify protein levels of SMAD2, SMAD4, and TGF-β3.
  • Statistical Analysis: Data were analyzed using ANOVA and t-tests (GraphPad Prism), with significance set at p < 0.05.

3. Key Results

A. Cytotoxicity (IC50 Values)

• General Trend: GenX demonstrated significantly lower cytotoxicity (higher IC50 values) than PFOA across all cell lines.
• Sensitivity Ranking:
  • Most Sensitive: A375 (Skin) and SW620 (Colon).
  • Most Resistant: SN12C (Kidney) and HepG2 (Liver).
• Specific Data:
  • A375: PFOA IC50 = 213.2 µM; GenX IC50 = 1,555 µM.
  • SN12C: PFOA IC50 = 616.3 µM; GenX IC50 = 5,048 µM.
  • HepG2: PFOA IC50 = 527.9 µM; GenX IC50 = 2,377 µM.

B. Molecular Pathway Perturbations

The study revealed compound-specific and tissue-specific modulation of stress pathways:

1. DNA Damage Response (p53, ATM, ATR) & Ribosomal Stress (RPL5, RPL11):

• HepG2 (Liver): Both PFOA and GenX induced a robust upregulation of ATM, ATR, p53, RPL5, and RPL11, indicating strong genotoxic and ribosomal stress.
• SN12C (Kidney): Showed divergent responses. PFOA suppressed these markers, while GenX upregulated them (dose-dependent).
• SW620 (Colon): Also showed divergent responses. PFOA upregulated DDR markers, whereas GenX downregulated them.
• A375 (Skin): PFOA induced ribosomal stress (RPL5/11) at IC50; GenX induced ATM upregulation but downregulated p53.

2. TGF-β/SMAD Signaling (Inflammation/Fibrosis):

• HepG2: Both compounds upregulated TGF-β1 and SMAD transcripts (SMAD2, 3, 4). However, protein levels of SMAD2/4 often decreased or remained unchanged, suggesting post-transcriptional regulation or degradation.
• SN12C: PFOA suppressed TGF-β/SMAD gene expression, while GenX induced it.
• SW620: PFOA enhanced SMAD expression, while GenX inhibited it.
• A375: PFOA increased SMAD2 and SMAD4 protein; GenX increased SMAD1/3/4 transcripts but decreased p53.

C. Summary of Divergence

• Liver (HepG2): Similar response profiles to both chemicals (activation of stress pathways).
• Kidney (SN12C) & Colon (SW620): Opposite responses. PFOA and GenX acted as antagonists in these tissues, with one compound often suppressing pathways that the other activated.

4. Key Contributions

1. Comparative Toxicology: Provides the first direct comparison of PFOA and GenX across four distinct human cell types, highlighting that "safer" replacements are not biologically inert.
2. Mechanistic Insight: Identifies ribosomal stress (via RPL5/RPL11) as a novel and significant target of PFAS toxicity, linking it to p53 activation.
3. Tissue Specificity: Demonstrates that PFAS toxicity is not uniform; the kidney and colon exhibit complex, opposing responses to legacy vs. replacement PFAS, challenging the assumption of a universal mechanism of action.
4. Pathway Decoupling: Reveals instances where gene transcription (mRNA) and protein translation (Western Blot) are decoupled (e.g., in HepG2), suggesting PFAS may disrupt translational efficiency or protein stability.

5. Significance and Implications

• Regulatory Policy: The findings challenge the regulatory assumption that GenX is a safe substitute for PFOA. While GenX is less acutely cytotoxic, it induces distinct and potentially harmful molecular stress responses (DNA damage, ribosomal stress, inflammation) that vary by tissue.
• Health Risk Assessment: The study underscores the need for tissue-specific risk assessments. A chemical deemed "safe" based on liver toxicity data may pose unique risks to the kidney or colon due to divergent signaling pathways.
• Future Directions: The authors recommend integrating systems-level approaches (proteomics, phospho-proteomics) to study post-translational modifications of p53 and SMADs. Future studies should also move beyond immortalized cancer lines to primary cells and incorporate physiologically based pharmacokinetic (PBPK) modeling to better align in vitro doses with in vivo exposure.

Conclusion: Reduced cytotoxicity (higher IC50) of GenX does not equate to biological safety. Both legacy and replacement PFAS disrupt critical cellular homeostasis mechanisms, but they do so through distinct, tissue-dependent mechanisms that require further investigation to fully understand long-term carcinogenic and inflammatory risks.